Pharmaceuticals

Albuked Market Revenue Growth Forecast To Reach $42.32 Billion By 2030 At 3.3% CAGR

May 5, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

What Is The Forecasted Market Size Trajectory Of The Albuked Market From 2026 To 2030?

Historically, the expansion witnessed was primarily driven by the medical application of albumin in shock treatment, a reliance on plasma-derived albumin, the increasing occurrence of liver disorders, the growth of hospital-based critical care, and albumin’s established efficacy in fluid management.

During the projected period, the observed growth is expected to stem from several factors, including the demand for safer non-plasma products, an increase in burn and trauma cases, the expansion of recombinant protein manufacturing, a rise in ICU admissions, and supportive regulations for synthetic proteins. Prominent trends anticipated in this forecast period encompass the wider adoption of recombinant albumin, a move away from plasma-derived albumin, an increase in its application within critical care settings, a growing preference for synthetic therapeutics, and the broader expansion of intravenous protein therapies.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/sample.aspx?id=19868&type=smp

Which Key Drivers Are Affecting The Albuked Market Development?

The escalating occurrence of liver conditions is projected to boost the expansion of the albuked market moving ahead. Liver disorders cover a range of ailments impacting liver function, such as hepatitis, cirrhosis, fatty liver disease, and autoimmune diseases. The increase in these disorders stems from factors like excessive alcohol consumption, obesity, viral infections, exposure to toxins, and genetic predispositions that harm liver health. Albuked finds application in liver disorders, especially for managing acute liver failure. It assists in maintaining the colloid osmotic pressure of plasma and binding surplus bilirubin in patients experiencing rapid loss of liver function, potentially averting complications like coma. For example, data from September 2023, provided by the American Liver Foundation, a US-based non-profit organization, indicates that over 100 million people in the U.S. suffer from some form of liver disease. Of these, 4.5 million adults (1.8%) have received a formal diagnosis, and an estimated 80-100 million adults in the U.S. have fatty liver disease, with many being unaware of their situation. Moreover, in August 2023, the Journal of Hepatology, a Switzerland-based peer-reviewed monthly journal, reported that liver disease contributes to over 2 million deaths annually, representing approximately 4% of all deaths worldwide. This implies that 1 in every 25 deaths is linked to liver problems. Significantly, one-third of these fatalities affect women. Among different liver diseases, liver cancer alone accounts for between 600,000 and 900,000 deaths each year. Consequently, the growing prevalence of liver disorders is a key driver for the Albuked market.

What Segment Categories Shape The Albuked Market Segment Landscape?

The albuked market covered in this report is segmented –

1) By Formulation: Albuked 5%, Albuked 25%, Plasbumin-5, Plasbumin-25

2) By Indication: Hypovolemic Shock, Hypoproteinemia, Acute Respiratory Distress Syndrome (ARDS), Cardiopulmonary Bypass, Acute Liver Failure

3) By Packaging Size: 50 mL, 250 mL, 500 mL

4) By Distribution Channel: Hospitals And Clinics, Retail And Specialty Pharmacies

5) By End User: Adult Patients, Geriatric Patients

Which Trends Are Shaping Growth In The Albuked Market?

A primary trend in the Albuked market involves concentrating on the development of sophisticated offerings like human albumin injection therapy to provide various treatment options for critical medical conditions. Human albumin injection therapy refers to the application of human serum albumin (HSA), a protein derived from human plasma, for diverse medical treatments. This therapy finds its main use in clinical environments to address conditions such as hypoalbuminemia, liver cirrhosis, trauma, burns, and during surgical operations requiring fluid resuscitation. For instance, in July 2023, Grifols S.A., a Spain-based manufacturer of plasma-derived medicines, reported the completion of phase 3 for PRECIOSA, a study designed to ascertain the potential of long-term albumin-based treatment using Grifols S.A.’s Albutein. This clinical study is intended to prolong the survival duration for patients experiencing decompensated cirrhosis and ascites until a suitable transplant becomes accessible.

Who Are The Companies Operating Across The Albuked Market Value Chain?

Major companies operating in the albuked market are Kedrion Biopharma Inc.

Get The Full Albuked Market Report:

https://www.thebusinessresearchcompany.com/report/albuked-global-market-report

Which Region Leads The Albuked Market In Overall Market Size?

North America was the largest region in the albuked market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the albuked market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Albuked Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/albuked-global-market-report

Browse Through More Reports Similar to the Global Albuked Market 2026, By The Business Research Company

Data Lake Market Report 2026

https://www.thebusinessresearchcompany.com/report/data-lake-global-market-report

Automated Algo Trading Market Report 2026

https://www.thebusinessresearchcompany.com/report/automated-algo-trading-global-market-report

Trade Finance Market Report 2026

https://www.thebusinessresearchcompany.com/report/trade-finance-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795